Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment
Samuel A. Kerk, Thales Papagiannakopoulos, Yatrik M. Shah, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 8, pp. 510-525
Open Access | Times Cited: 153

Showing 51-75 of 153 citing articles:

Targeting the crosstalk between glutamine metabolism and tumor immune microenvironment for lung cancer immunotherapy
Jingyang Li, Xiang Li, Shaohui Wang, et al.
Deleted Journal (2025)
Open Access
Investigation of sphingolipid-related genes in lung adenocarcinoma
Jennifer Mao, Li Li, Hui Sun, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access
Blockade of mutant RAS oncogenic signaling with a special emphasis on KRAS
Robert Roskoski
Pharmacological Research (2021) Vol. 172, pp. 105806-105806
Closed Access | Times Cited: 27
Ketogenic Diets in Pancreatic Cancer and Associated Cachexia: Cellular Mechanisms and Clinical Perspectives
Natalia E. Cortez, Gerardo G. Mackenzie
Nutrients (2021) Vol. 13, Iss. 9, pp. 3202-3202
Open Access | Times Cited: 27
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
Keiji Kurata, Anna James-Bott, Mark A. Tye, et al.
Blood Cancer Journal (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Homeostatic regulation of NAD(H) and NADP(H) in cells
Luojun Chen, Xiaoke Xing, Pingfeng Zhang, et al.
Genes & Diseases (2023) Vol. 11, Iss. 5, pp. 101146-101146
Open Access | Times Cited: 12
Metabolic Connectome and Its Role in the Prediction, Diagnosis, and Treatment of Complex Diseases
Weiyu Meng, Hongxin Pan, Yuyang Sha, et al.
Metabolites (2024) Vol. 14, Iss. 2, pp. 93-93
Open Access | Times Cited: 4
FGFR inhibition blocks NF-ĸB-dependent glucose metabolism and confers metabolic vulnerabilities in cholangiocarcinoma
Yuanli Zhen, Kai Liu, Lei Shi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy
Chen Chen, Peng Han, Yanping Qing
Autoimmunity Reviews (2024) Vol. 23, Iss. 6, pp. 103579-103579
Closed Access | Times Cited: 4
Mimicking and analyzing the tumor microenvironment
Roxane Crouigneau, Yanfang Li, Jamie Auxillos, et al.
Cell Reports Methods (2024) Vol. 4, Iss. 10, pp. 100866-100866
Open Access | Times Cited: 4
Crosstalk between KRAS, SRC and YAP Signaling in Pancreatic Cancer: Interactions Leading to Aggressive Disease and Drug Resistance
Enrique Rozengurt, Guido Eibl
Cancers (2021) Vol. 13, Iss. 20, pp. 5126-5126
Open Access | Times Cited: 23
The Role of RAB GTPases and Its Potential in Predicting Immunotherapy Response and Prognosis in Colorectal Cancer
Xuefei Jiang, Lanlan Yang, Qianling Gao, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 17
Integrated single-cell RNA-seq analysis identifies immune heterogeneity associated with KRAS/TP53 mutation status and tumor-sideness in colorectal cancers
Xiaoyu Liu, Xu Xu, Zhuozhuo Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Tumor Cell Derived Exosomal GOT1 Suppresses Tumor Cell Ferroptosis to Accelerate Pancreatic Cancer Progression by Activating Nrf2/HO-1 Axis via Upregulating CCR2 Expression
Yao Guo, Taoyu Chen, Xueyi Liang, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3893-3893
Open Access | Times Cited: 16
p38γ MAPK Inflammatory and Metabolic Signaling in Physiology and Disease
Xiao-Mei Qi, Guan Chen
Cells (2023) Vol. 12, Iss. 13, pp. 1674-1674
Open Access | Times Cited: 10
Spotlight on GOT2 in Cancer Metabolism
Samuel A. Kerk, Javier García‐Bermúdez, Kıvanç Birsoy, et al.
OncoTargets and Therapy (2023) Vol. Volume 16, pp. 695-702
Open Access | Times Cited: 10
Targeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in pancreatic cancer
Caleb Cheng, Jing Hu, Rahul Mannan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Exploring the potential of asparagine restriction in solid cancer treatment: recent discoveries, therapeutic implications, and challenges
Marina Gabriel Fontes, Carolina Silva, William H. Roldán, et al.
Medical Oncology (2024) Vol. 41, Iss. 7
Closed Access | Times Cited: 3
Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of KRAS -Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial
Daniel H. Ahn, Maya Ridinger, Timothy Lewis Cannon, et al.
Journal of Clinical Oncology (2024)
Closed Access | Times Cited: 3
Mechanistic Insights of Polyphenolic Compounds from Rosemary Bound to Their Protein Targets Obtained by Molecular Dynamics Simulations and Free-Energy Calculations
Samo Lešnik, Marko Jukič, Urban Bren
Foods (2023) Vol. 12, Iss. 2, pp. 408-408
Open Access | Times Cited: 8
TFR1-Mediated Iron Metabolism Orchestrates Tumor Ferroptosis and Immunity in Non-Small Cell Lung Cancer
Zunqiao Wang, Xingkai Yao, Keping Wang, et al.
Journal of Environmental Pathology Toxicology and Oncology (2023) Vol. 43, Iss. 2, pp. 1-12
Closed Access | Times Cited: 8
Targeting dysregulated lipid metabolism in the tumor microenvironment
Do‐Hee Kim, Na‐Young Song, Hyungshin Yim
Archives of Pharmacal Research (2023) Vol. 46, Iss. 11-12, pp. 855-881
Open Access | Times Cited: 8
MEK inhibition suppresses metastatic progression of KRAS‐mutated gastric cancer
Juntaro Yamasaki, Yuki Hirata, Yuji Otsuki, et al.
Cancer Science (2021) Vol. 113, Iss. 3, pp. 916-925
Open Access | Times Cited: 19
Divergent Roles of Mitochondria Dynamics in Pancreatic Ductal Adenocarcinoma
Cristian Andrés Carmona-Carmona, Elisa Dalla Pozza, Giulia Ambrosini, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2155-2155
Open Access | Times Cited: 13
Targeting autophagy in colorectal cancer: An update on pharmacological small-molecule compounds
Zixiang Li, Wen Si, Wenke Jin, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 8, pp. 2373-2385
Closed Access | Times Cited: 13

Scroll to top